NVS seeking bids for US small-molecule-generics business: https://www.reuters.com/article/us-novartis-genericdrugs/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUSKCN1G01SW FoBs and “complex” generics such as Copaxone are not part of the planned divestiture.